Skin with albinism: an invisible dermatological emergency
In sub-Saharan Africa, the sun is not an abstract threat. For those born with albinism, it represents a constant source of physical harm. The lack of melanin in the skin leaves the body fully exposed to the effects of ultraviolet radiation, dramatically increasing the risk of burns, precancerous lesions, and skin cancer from a very early age.
This vulnerability is not merely theoretical: in rural areas, where access to sun protection is limited or nonexistent, the consequences are visible, painful, and often fatal. Many people with albinism die from skin cancer before the age of 40, even though it is a preventable disease. Without access to adapted products, daily sun exposure leaves deep marks, both physical and social.
Common sunscreens do not provide sufficient protection
Offering just any sunscreen is not enough. Most products available on the market are not designed for extremely sensitive skin, nor for climates with high temperatures, humidity, constant sweating, and intense sun exposure.
Moreover, in many rural areas of Africa, available formulas leave white residue on the skin, have heavy textures, or cause irritation. This discourages use, especially when combined with stares, comments, or stigma. Without frequent reapplication and proper educational support, effectiveness is lost.
Real sun protection for people with albinism cannot depend on chance or sporadic charity. It requires solutions designed with dermatology, logistics, and context in mind.
UMOZI MAX: an effective response, rooted in science and solidarity
Faced with this reality, Beyond Suncare developed a dermatologically effective and socially responsible solution: UMOZI MAX.

What should a sunscreen adapted to albinism include?
UMOZI MAX has been formulated according to very precise scientific, dermatological, and social criteria. For a sunscreen to be truly effective in this context, it must meet the following requirements:
Evidencia científica: estudio piloto en –
Scientific evidence: pilot study in Malawi
Between February and May 2019, a pioneering study was conducted in Malawi to assess the real-world effectiveness of UMOZI MAX, accompanied by educational training. The research, published in 2022 in the International Journal of Dermatology, analyzed the impact of continuous use of the product among people with albinism.
The results were clear: participants reported a significant reduction in sunburns, a visible improvement in overall skin condition, and high acceptance of the product. Prior education facilitated correct application and encouraged daily reapplication—an essential factor in achieving effective protection.
This study demonstrates that it is not only possible to create an effective sunscreen for people with albinism, but that doing so with a community-based approach is indispensable. You can consult the full publication here:
Gilaberte et al., 2022 – PubMed
More than a cream: an inclusive strategy
UMOZI MAX is part of a comprehensive model of health, rights, and empowerment. At Beyond Suncare, we believe that sun protection should not depend on privilege. That is why we work to ensure free access, healthcare training, and awareness-raising at all levels.
Each tube of UMOZI MAX distributed represents far more than a layer of protection: it stands for respect, autonomy, and the right to live without fear of the sun.



Evidencia científica: estudio piloto en –